Form4insider filings, from the source

SEC Form 4 · accession 0001645627-17-000070

ENDONOVO THERAPEUTICS, INC. · ENDV

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
May 23, 2017
Accepted (ET)
May 26, 2017 · 12:32 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMay 23, 2017P1,000$0.06A20,958,249D
Common StockMay 23, 2017P1,000$0.06A20,959,249D
Common StockMay 23, 2017P1,000$0.06A20,960,249D
Common StockMay 23, 2017P1,000$0.06A20,961,249D
Common StockMay 23, 2017P1,000$0.06A20,962,249D
Common StockMay 23, 2017P1,000$0.0607A20,963,249D
Common StockMay 23, 2017P1,000$0.061A20,964,249D
Common StockMay 23, 2017P1,000$0.061A20,965,249D
Common StockMay 23, 2017P1,000$0.061A20,965,249D
Common StockMay 24, 2017P1,000$0.06A20,966,249D
Common StockMay 24, 2017P1,000$0.06A20,967,249D
Common StockMay 24, 2017P1,000$0.0627A20,968,249D
Common StockMay 24, 2017P1,000$0.06A20,969,249D
Common StockMay 24, 2017P1,000$0.06A20,970,249D
Common StockMay 24, 2017P1,000$0.06A20,971,249D
Common StockMay 24, 2017P1,000$0.0599A20,972,249D
Common StockMay 24, 2017P1,000$0.06A20,973,249D
Common StockMay 24, 2017P1,000$0.06A20,974,249D
Common StockMay 24, 2017P1,000$0.06A20,975,249D
Common StockMay 24, 2017P1,000$0.06A20,976,249D
Common StockMay 24, 2017P1,000$0.06A20,977,249D
Common StockMay 24, 2017P1,000$0.06A20,978,249D
Common StockMay 24, 2017P1,000$0.06A20,979,249D
Common StockMay 24, 2017P1,000$0.06A20,980,249D
Common StockMay 24, 2017P1,000$0.06A20,981,249D
Common StockMay 24, 2017P1,000$0.058A20,982,249D
Common StockMay 24, 2017P1,000$0.058A20,983,249D
Common StockMay 24, 2017P1,000$0.06A20,984,249D
Common StockMay 24, 2017P1,000$0.058A20,985,249D
Common StockMay 24, 2017P1,000$0.0578A20,986,249D

Table II — derivative securities

No Table II lines on this filing.